The co-occurrence of MS and LRRK2 PD, although rare, further supports an important role for immune function in LRRK2 PD and that MS may be an expression of the LRRK2 G2019S variant that includes both MS and PD, with MS predating features characteristic of PD. This evidence concerns the gene LRRK2 and myeloid sarcoma.